Cargando…
Comparison of renal remission and relapse‐free rate in initial‐ and delayed‐onset lupus nephritis
INTRODUCTION: Lupus nephritis (LN) is a major manifestation of systemic lupus erythematosus (SLE) which contributes to significant morbidity and mortality. It is unclear whether the timing of LN onset influences renal outcome. This study aimed to investigate differences in clinical features—particul...
Autores principales: | Suzuki, Eiji, Yashiro‐Furuya, Makiko, Temmoku, Jumpei, Fujita, Yuya, Matsuoka, Naoki, Hazama, Momoko, Asano, Tomoyuki, Sato, Shuzo, Kobayashi, Hiroko, Watanabe, Hiroshi, Kanno, Takashi, Migita, Kiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292939/ https://www.ncbi.nlm.nih.gov/pubmed/34636151 http://dx.doi.org/10.1111/1756-185X.14228 |
Ejemplares similares
-
Ets Family Transcription Factor Fli-1 Promotes Leukocyte Recruitment and Production of IL-17A in the MRL/Lpr Mouse Model of Lupus Nephritis
por: Sato, Shuzo, et al.
Publicado: (2020) -
Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers
por: Sato, Shuzo, et al.
Publicado: (2020) -
Serum Levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule 3 in Patients with Systemic Lupus Erythematosus
por: Asano, Tomoyuki, et al.
Publicado: (2020) -
Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis: Two case reports
por: Asano, Tomoyuki, et al.
Publicado: (2020) -
Sustained Long-Term Retention Rates of Abatacept in Combination with Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis
por: Sato, Shuzo, et al.
Publicado: (2021)